The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Apigeninidin Market Research Report 2025
Synopsis
Apigeninidin (Also, apigenidin,or Gesneridin) is a chemical compound belonging to the 3-deoxyanthocyanidins and that can be found in the Patagonian plant Ephedra frustillata and in the soybean. Apigeninidin is one of the principal pigments found in sorghum. Extremely high level of apigeninidin (49 mg/g) has been documented in sorghum leaf sheath. Like all anthocyanidins it exists in a variety of tautomers depending on pH and hydration, several of these bare the distinctive pyrylium core.Apigenin is a protein kinase inhibitor. Suppresses tumor-promoting effects of TPA and exhibits antiproliferative activity in human breast cancer cells (IC50 values are 59.44 and 31.15 μM at 24 and 72 hrs respectively). Activates both the intrinsic and extrinsic apoptotic pathways and displays anti-inflammatory, hypotensive, antispasmodic and antioxidant properties in vivo.Apigenin, found in many plants, is a natural product belonging to the flavone class that is the aglycone of several naturally-occurring glycosides. Apigenin acts as a monoamine transporter activator, one of the few chemicals demonstrated to possess this property. Apigenin is a ligand for central benzodiazepine receptors that competitively inhibited the binding of flunitrazepam with a Ki of 4μM, exerting anxiolytic and slight sedative effects.
The global Apigeninidin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Apigeninidin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Apigeninidin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Apigeninidin include Bio-techne, Creative Enzymes, MedChemExpress, Biosynth Carbosynth, United States Biological, Molekula, BOC Sciences, FoodChem and Focus Biomolecules, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Apigeninidin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apigeninidin.
Report Scope
The Apigeninidin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apigeninidin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apigeninidin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-techne
Creative Enzymes
MedChemExpress
Biosynth Carbosynth
United States Biological
Molekula
BOC Sciences
FoodChem
Focus Biomolecules
Ottokemi
BioCrick
Lanyor
NEO Biotech
ChemFaces
Cayman
Sigma-Aldrich
Segment by Type
Powder
Crystalline Solid
Others
Segment by Application
Food Industry
Medical Care
Scientific Research
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apigeninidin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apigeninidin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Apigeninidin (Also, apigenidin,or Gesneridin) is a chemical compound belonging to the 3-deoxyanthocyanidins and that can be found in the Patagonian plant Ephedra frustillata and in the soybean. Apigeninidin is one of the principal pigments found in sorghum. Extremely high level of apigeninidin (49 mg/g) has been documented in sorghum leaf sheath. Like all anthocyanidins it exists in a variety of tautomers depending on pH and hydration, several of these bare the distinctive pyrylium core.Apigenin is a protein kinase inhibitor. Suppresses tumor-promoting effects of TPA and exhibits antiproliferative activity in human breast cancer cells (IC50 values are 59.44 and 31.15 μM at 24 and 72 hrs respectively). Activates both the intrinsic and extrinsic apoptotic pathways and displays anti-inflammatory, hypotensive, antispasmodic and antioxidant properties in vivo.Apigenin, found in many plants, is a natural product belonging to the flavone class that is the aglycone of several naturally-occurring glycosides. Apigenin acts as a monoamine transporter activator, one of the few chemicals demonstrated to possess this property. Apigenin is a ligand for central benzodiazepine receptors that competitively inhibited the binding of flunitrazepam with a Ki of 4μM, exerting anxiolytic and slight sedative effects.
The global Apigeninidin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Apigeninidin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Apigeninidin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Apigeninidin include Bio-techne, Creative Enzymes, MedChemExpress, Biosynth Carbosynth, United States Biological, Molekula, BOC Sciences, FoodChem and Focus Biomolecules, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Apigeninidin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apigeninidin.
Report Scope
The Apigeninidin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apigeninidin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apigeninidin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-techne
Creative Enzymes
MedChemExpress
Biosynth Carbosynth
United States Biological
Molekula
BOC Sciences
FoodChem
Focus Biomolecules
Ottokemi
BioCrick
Lanyor
NEO Biotech
ChemFaces
Cayman
Sigma-Aldrich
Segment by Type
Powder
Crystalline Solid
Others
Segment by Application
Food Industry
Medical Care
Scientific Research
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apigeninidin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apigeninidin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Apigeninidin Market Overview
1.1 Product Overview and Scope of Apigeninidin
1.2 Apigeninidin Segment by Type
1.2.1 Global Apigeninidin Market Value Comparison by Type (2024-2030)
1.2.2 Powder
1.2.3 Crystalline Solid
1.2.4 Others
1.3 Apigeninidin Segment by Application
1.3.1 Global Apigeninidin Market Value by Application: (2024-2030)
1.3.2 Food Industry
1.3.3 Medical Care
1.3.4 Scientific Research
1.3.5 Others
1.4 Global Apigeninidin Market Size Estimates and Forecasts
1.4.1 Global Apigeninidin Revenue 2019-2030
1.4.2 Global Apigeninidin Sales 2019-2030
1.4.3 Global Apigeninidin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Apigeninidin Market Competition by Manufacturers
2.1 Global Apigeninidin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Apigeninidin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Apigeninidin Average Price by Manufacturers (2019-2024)
2.4 Global Apigeninidin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Apigeninidin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Apigeninidin, Product Type & Application
2.7 Apigeninidin Market Competitive Situation and Trends
2.7.1 Apigeninidin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Apigeninidin Players Market Share by Revenue
2.7.3 Global Apigeninidin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Apigeninidin Retrospective Market Scenario by Region
3.1 Global Apigeninidin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Apigeninidin Global Apigeninidin Sales by Region: 2019-2030
3.2.1 Global Apigeninidin Sales by Region: 2019-2024
3.2.2 Global Apigeninidin Sales by Region: 2025-2030
3.3 Global Apigeninidin Global Apigeninidin Revenue by Region: 2019-2030
3.3.1 Global Apigeninidin Revenue by Region: 2019-2024
3.3.2 Global Apigeninidin Revenue by Region: 2025-2030
3.4 North America Apigeninidin Market Facts & Figures by Country
3.4.1 North America Apigeninidin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Apigeninidin Sales by Country (2019-2030)
3.4.3 North America Apigeninidin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Apigeninidin Market Facts & Figures by Country
3.5.1 Europe Apigeninidin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Apigeninidin Sales by Country (2019-2030)
3.5.3 Europe Apigeninidin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Apigeninidin Market Facts & Figures by Country
3.6.1 Asia Pacific Apigeninidin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Apigeninidin Sales by Country (2019-2030)
3.6.3 Asia Pacific Apigeninidin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Apigeninidin Market Facts & Figures by Country
3.7.1 Latin America Apigeninidin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Apigeninidin Sales by Country (2019-2030)
3.7.3 Latin America Apigeninidin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Apigeninidin Market Facts & Figures by Country
3.8.1 Middle East and Africa Apigeninidin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Apigeninidin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Apigeninidin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Apigeninidin Sales by Type (2019-2030)
4.1.1 Global Apigeninidin Sales by Type (2019-2024)
4.1.2 Global Apigeninidin Sales by Type (2025-2030)
4.1.3 Global Apigeninidin Sales Market Share by Type (2019-2030)
4.2 Global Apigeninidin Revenue by Type (2019-2030)
4.2.1 Global Apigeninidin Revenue by Type (2019-2024)
4.2.2 Global Apigeninidin Revenue by Type (2025-2030)
4.2.3 Global Apigeninidin Revenue Market Share by Type (2019-2030)
4.3 Global Apigeninidin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Apigeninidin Sales by Application (2019-2030)
5.1.1 Global Apigeninidin Sales by Application (2019-2024)
5.1.2 Global Apigeninidin Sales by Application (2025-2030)
5.1.3 Global Apigeninidin Sales Market Share by Application (2019-2030)
5.2 Global Apigeninidin Revenue by Application (2019-2030)
5.2.1 Global Apigeninidin Revenue by Application (2019-2024)
5.2.2 Global Apigeninidin Revenue by Application (2025-2030)
5.2.3 Global Apigeninidin Revenue Market Share by Application (2019-2030)
5.3 Global Apigeninidin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bio-techne
6.1.1 Bio-techne Corporation Information
6.1.2 Bio-techne Description and Business Overview
6.1.3 Bio-techne Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bio-techne Apigeninidin Product Portfolio
6.1.5 Bio-techne Recent Developments/Updates
6.2 Creative Enzymes
6.2.1 Creative Enzymes Corporation Information
6.2.2 Creative Enzymes Description and Business Overview
6.2.3 Creative Enzymes Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Creative Enzymes Apigeninidin Product Portfolio
6.2.5 Creative Enzymes Recent Developments/Updates
6.3 MedChemExpress
6.3.1 MedChemExpress Corporation Information
6.3.2 MedChemExpress Description and Business Overview
6.3.3 MedChemExpress Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MedChemExpress Apigeninidin Product Portfolio
6.3.5 MedChemExpress Recent Developments/Updates
6.4 Biosynth Carbosynth
6.4.1 Biosynth Carbosynth Corporation Information
6.4.2 Biosynth Carbosynth Description and Business Overview
6.4.3 Biosynth Carbosynth Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biosynth Carbosynth Apigeninidin Product Portfolio
6.4.5 Biosynth Carbosynth Recent Developments/Updates
6.5 United States Biological
6.5.1 United States Biological Corporation Information
6.5.2 United States Biological Description and Business Overview
6.5.3 United States Biological Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 United States Biological Apigeninidin Product Portfolio
6.5.5 United States Biological Recent Developments/Updates
6.6 Molekula
6.6.1 Molekula Corporation Information
6.6.2 Molekula Description and Business Overview
6.6.3 Molekula Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Molekula Apigeninidin Product Portfolio
6.6.5 Molekula Recent Developments/Updates
6.7 BOC Sciences
6.6.1 BOC Sciences Corporation Information
6.6.2 BOC Sciences Description and Business Overview
6.6.3 BOC Sciences Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BOC Sciences Apigeninidin Product Portfolio
6.7.5 BOC Sciences Recent Developments/Updates
6.8 FoodChem
6.8.1 FoodChem Corporation Information
6.8.2 FoodChem Description and Business Overview
6.8.3 FoodChem Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 FoodChem Apigeninidin Product Portfolio
6.8.5 FoodChem Recent Developments/Updates
6.9 Focus Biomolecules
6.9.1 Focus Biomolecules Corporation Information
6.9.2 Focus Biomolecules Description and Business Overview
6.9.3 Focus Biomolecules Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Focus Biomolecules Apigeninidin Product Portfolio
6.9.5 Focus Biomolecules Recent Developments/Updates
6.10 Ottokemi
6.10.1 Ottokemi Corporation Information
6.10.2 Ottokemi Description and Business Overview
6.10.3 Ottokemi Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ottokemi Apigeninidin Product Portfolio
6.10.5 Ottokemi Recent Developments/Updates
6.11 BioCrick
6.11.1 BioCrick Corporation Information
6.11.2 BioCrick Apigeninidin Description and Business Overview
6.11.3 BioCrick Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BioCrick Apigeninidin Product Portfolio
6.11.5 BioCrick Recent Developments/Updates
6.12 Lanyor
6.12.1 Lanyor Corporation Information
6.12.2 Lanyor Apigeninidin Description and Business Overview
6.12.3 Lanyor Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Lanyor Apigeninidin Product Portfolio
6.12.5 Lanyor Recent Developments/Updates
6.13 NEO Biotech
6.13.1 NEO Biotech Corporation Information
6.13.2 NEO Biotech Apigeninidin Description and Business Overview
6.13.3 NEO Biotech Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 NEO Biotech Apigeninidin Product Portfolio
6.13.5 NEO Biotech Recent Developments/Updates
6.14 ChemFaces
6.14.1 ChemFaces Corporation Information
6.14.2 ChemFaces Apigeninidin Description and Business Overview
6.14.3 ChemFaces Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ChemFaces Apigeninidin Product Portfolio
6.14.5 ChemFaces Recent Developments/Updates
6.15 Cayman
6.15.1 Cayman Corporation Information
6.15.2 Cayman Apigeninidin Description and Business Overview
6.15.3 Cayman Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cayman Apigeninidin Product Portfolio
6.15.5 Cayman Recent Developments/Updates
6.16 Sigma-Aldrich
6.16.1 Sigma-Aldrich Corporation Information
6.16.2 Sigma-Aldrich Apigeninidin Description and Business Overview
6.16.3 Sigma-Aldrich Apigeninidin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sigma-Aldrich Apigeninidin Product Portfolio
6.16.5 Sigma-Aldrich Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Apigeninidin Industry Chain Analysis
7.2 Apigeninidin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Apigeninidin Production Mode & Process
7.4 Apigeninidin Sales and Marketing
7.4.1 Apigeninidin Sales Channels
7.4.2 Apigeninidin Distributors
7.5 Apigeninidin Customers
8 Apigeninidin Market Dynamics
8.1 Apigeninidin Industry Trends
8.2 Apigeninidin Market Drivers
8.3 Apigeninidin Market Challenges
8.4 Apigeninidin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Apigeninidin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Apigeninidin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Apigeninidin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Apigeninidin Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Apigeninidin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Apigeninidin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Apigeninidin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Apigeninidin Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Apigeninidin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Apigeninidin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Apigeninidin, Product Type & Application
Table 12. Global Key Manufacturers of Apigeninidin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Apigeninidin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apigeninidin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Apigeninidin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Apigeninidin Sales by Region (2019-2024) & (Tons)
Table 18. Global Apigeninidin Sales Market Share by Region (2019-2024)
Table 19. Global Apigeninidin Sales by Region (2025-2030) & (Tons)
Table 20. Global Apigeninidin Sales Market Share by Region (2025-2030)
Table 21. Global Apigeninidin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Apigeninidin Revenue Market Share by Region (2019-2024)
Table 23. Global Apigeninidin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Apigeninidin Revenue Market Share by Region (2025-2030)
Table 25. North America Apigeninidin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Apigeninidin Sales by Country (2019-2024) & (Tons)
Table 27. North America Apigeninidin Sales by Country (2025-2030) & (Tons)
Table 28. North America Apigeninidin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Apigeninidin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Apigeninidin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Apigeninidin Sales by Country (2019-2024) & (Tons)
Table 32. Europe Apigeninidin Sales by Country (2025-2030) & (Tons)
Table 33. Europe Apigeninidin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Apigeninidin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Apigeninidin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Apigeninidin Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Apigeninidin Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Apigeninidin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Apigeninidin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Apigeninidin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Apigeninidin Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Apigeninidin Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Apigeninidin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Apigeninidin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Apigeninidin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Apigeninidin Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa Apigeninidin Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa Apigeninidin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Apigeninidin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Apigeninidin Sales (Tons) by Type (2019-2024)
Table 51. Global Apigeninidin Sales (Tons) by Type (2025-2030)
Table 52. Global Apigeninidin Sales Market Share by Type (2019-2024)
Table 53. Global Apigeninidin Sales Market Share by Type (2025-2030)
Table 54. Global Apigeninidin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Apigeninidin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Apigeninidin Revenue Market Share by Type (2019-2024)
Table 57. Global Apigeninidin Revenue Market Share by Type (2025-2030)
Table 58. Global Apigeninidin Price (US$/Ton) by Type (2019-2024)
Table 59. Global Apigeninidin Price (US$/Ton) by Type (2025-2030)
Table 60. Global Apigeninidin Sales (Tons) by Application (2019-2024)
Table 61. Global Apigeninidin Sales (Tons) by Application (2025-2030)
Table 62. Global Apigeninidin Sales Market Share by Application (2019-2024)
Table 63. Global Apigeninidin Sales Market Share by Application (2025-2030)
Table 64. Global Apigeninidin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Apigeninidin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Apigeninidin Revenue Market Share by Application (2019-2024)
Table 67. Global Apigeninidin Revenue Market Share by Application (2025-2030)
Table 68. Global Apigeninidin Price (US$/Ton) by Application (2019-2024)
Table 69. Global Apigeninidin Price (US$/Ton) by Application (2025-2030)
Table 70. Bio-techne Corporation Information
Table 71. Bio-techne Description and Business Overview
Table 72. Bio-techne Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Bio-techne Apigeninidin Product
Table 74. Bio-techne Recent Developments/Updates
Table 75. Creative Enzymes Corporation Information
Table 76. Creative Enzymes Description and Business Overview
Table 77. Creative Enzymes Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Creative Enzymes Apigeninidin Product
Table 79. Creative Enzymes Recent Developments/Updates
Table 80. MedChemExpress Corporation Information
Table 81. MedChemExpress Description and Business Overview
Table 82. MedChemExpress Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. MedChemExpress Apigeninidin Product
Table 84. MedChemExpress Recent Developments/Updates
Table 85. Biosynth Carbosynth Corporation Information
Table 86. Biosynth Carbosynth Description and Business Overview
Table 87. Biosynth Carbosynth Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Biosynth Carbosynth Apigeninidin Product
Table 89. Biosynth Carbosynth Recent Developments/Updates
Table 90. United States Biological Corporation Information
Table 91. United States Biological Description and Business Overview
Table 92. United States Biological Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. United States Biological Apigeninidin Product
Table 94. United States Biological Recent Developments/Updates
Table 95. Molekula Corporation Information
Table 96. Molekula Description and Business Overview
Table 97. Molekula Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Molekula Apigeninidin Product
Table 99. Molekula Recent Developments/Updates
Table 100. BOC Sciences Corporation Information
Table 101. BOC Sciences Description and Business Overview
Table 102. BOC Sciences Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. BOC Sciences Apigeninidin Product
Table 104. BOC Sciences Recent Developments/Updates
Table 105. FoodChem Corporation Information
Table 106. FoodChem Description and Business Overview
Table 107. FoodChem Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. FoodChem Apigeninidin Product
Table 109. FoodChem Recent Developments/Updates
Table 110. Focus Biomolecules Corporation Information
Table 111. Focus Biomolecules Description and Business Overview
Table 112. Focus Biomolecules Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Focus Biomolecules Apigeninidin Product
Table 114. Focus Biomolecules Recent Developments/Updates
Table 115. Ottokemi Corporation Information
Table 116. Ottokemi Description and Business Overview
Table 117. Ottokemi Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Ottokemi Apigeninidin Product
Table 119. Ottokemi Recent Developments/Updates
Table 120. BioCrick Corporation Information
Table 121. BioCrick Description and Business Overview
Table 122. BioCrick Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. BioCrick Apigeninidin Product
Table 124. BioCrick Recent Developments/Updates
Table 125. Lanyor Corporation Information
Table 126. Lanyor Description and Business Overview
Table 127. Lanyor Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. Lanyor Apigeninidin Product
Table 129. Lanyor Recent Developments/Updates
Table 130. NEO Biotech Corporation Information
Table 131. NEO Biotech Description and Business Overview
Table 132. NEO Biotech Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 133. NEO Biotech Apigeninidin Product
Table 134. NEO Biotech Recent Developments/Updates
Table 135. ChemFaces Corporation Information
Table 136. ChemFaces Description and Business Overview
Table 137. ChemFaces Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 138. ChemFaces Apigeninidin Product
Table 139. ChemFaces Recent Developments/Updates
Table 140. Cayman Corporation Information
Table 141. Cayman Description and Business Overview
Table 142. Cayman Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 143. Cayman Apigeninidin Product
Table 144. Cayman Recent Developments/Updates
Table 145. Sigma-Aldrich Corporation Information
Table 146. Sigma-Aldrich Description and Business Overview
Table 147. Sigma-Aldrich Apigeninidin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 148. Sigma-Aldrich Apigeninidin Product
Table 149. Sigma-Aldrich Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Apigeninidin Distributors List
Table 153. Apigeninidin Customers List
Table 154. Apigeninidin Market Trends
Table 155. Apigeninidin Market Drivers
Table 156. Apigeninidin Market Challenges
Table 157. Apigeninidin Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Apigeninidin
Figure 2. Global Apigeninidin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Apigeninidin Market Share by Type in 2023 & 2030
Figure 4. Powder Product Picture
Figure 5. Crystalline Solid Product Picture
Figure 6. Others Product Picture
Figure 7. Global Apigeninidin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Apigeninidin Market Share by Application in 2023 & 2030
Figure 9. Food Industry
Figure 10. Medical Care
Figure 11. Scientific Research
Figure 12. Others
Figure 13. Global Apigeninidin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Apigeninidin Market Size (2019-2030) & (US$ Million)
Figure 15. Global Apigeninidin Sales (2019-2030) & (Tons)
Figure 16. Global Apigeninidin Average Price (US$/Ton) & (2019-2030)
Figure 17. Apigeninidin Report Years Considered
Figure 18. Apigeninidin Sales Share by Manufacturers in 2023
Figure 19. Global Apigeninidin Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Apigeninidin Players: Market Share by Revenue in 2023
Figure 21. Apigeninidin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Apigeninidin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Apigeninidin Sales Market Share by Country (2019-2030)
Figure 24. North America Apigeninidin Revenue Market Share by Country (2019-2030)
Figure 25. United States Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Apigeninidin Sales Market Share by Country (2019-2030)
Figure 28. Europe Apigeninidin Revenue Market Share by Country (2019-2030)
Figure 29. Germany Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Apigeninidin Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Apigeninidin Revenue Market Share by Region (2019-2030)
Figure 36. China Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Apigeninidin Sales Market Share by Country (2019-2030)
Figure 46. Latin America Apigeninidin Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Apigeninidin Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Apigeninidin Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Apigeninidin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Apigeninidin by Type (2019-2030)
Figure 56. Global Revenue Market Share of Apigeninidin by Type (2019-2030)
Figure 57. Global Apigeninidin Price (US$/Ton) by Type (2019-2030)
Figure 58. Global Sales Market Share of Apigeninidin by Application (2019-2030)
Figure 59. Global Revenue Market Share of Apigeninidin by Application (2019-2030)
Figure 60. Global Apigeninidin Price (US$/Ton) by Application (2019-2030)
Figure 61. Apigeninidin Value Chain
Figure 62. Apigeninidin Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
